The two organizations say the collaboration illustrates how health systems can pool resources and work together to address issues like staffing shortages.
“Ovatient shifts care away from traditional care delivery sites and brings it to the customer,” said Michael Dalton, Ovatient CEO and entrepreneur-in-residence at MetroHealth, in a joint Oct. 24 news release. “With Ovatient’s proprietary platform, we will accelerate and scale it, not just across MetroHealth and MUSC but to other health systems throughout the country.”
The two entities say Ovatient will also allow them to compete with “nontraditional healthcare providers” trying to enter the market while keeping patients connected with their acute and procedural care sites. The new venture is “built by health systems, for health systems,” stated MUSC Health CEO Patrick Cawley, MD.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit